Mukul Agrawal stock, specializing in the research, development, manufacture, and commercialization of biological drug products in various injectable formats, jumped upto 5 percent following the bulk deal involving Motilal Oswal Mutual Fund
Price action
With a market capitalization of Rs.18,008 crores on Monday, the shares of OneSource Specialty Pharma Limited were down by 4.5 percent in Intraday’s trade making a low of Rs. 1,427.45 per share and compared to the closing price of Rs. 1,502.45 per share.
What Happened
OneSource Specialty Pharma Limited, a company specializing in the research, development, manufacture, and commercialization of biological drug products, recently experienced a bulk deal in which Motilal Oswal Mutual Fund A/C Motilal Oswal Large and Midcap Fund purchased a 0.92 percent stake. In this transaction, 10.55 lakh shares were purchased at Rs. 1,545 each, resulting in a total value of around Rs. 163 Crores.
About the Company
OneSource Specialty Pharma Limited is a global pharmaceutical company specializing in the development, manufacturing, and commercialization of niche and complex medicines. The company focuses on providing high-quality specialty drugs in therapeutic areas like oncology, neurology, and infectious diseases.
Ace Investor
Ace Investor Mukul Mahavir Agrawal holds 16,30,147 shares in the company which consists of a 1.42 stake as of December 2024.
Financials
The company’s revenue rose by 496 percent from Rs. 57.32 crore to Rs. 341.76 crore in Q3FY24-25. Meanwhile, Net loss reduced from a loss of Rs. 130 crore to a loss of Rs. 73.02 crore during the same period.
Written by Sridhar J
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Mukul Agrawal stock in focus after Motilal Oswal bought stake in the company appeared first on Trade Brains.